Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel palladium-catalyzed bis-carbonylation route offers high yields and substrate compatibility for scalable pharmaceutical intermediate manufacturing.
Patent CN115286609B details a novel ruthenium-catalyzed route ensuring high purity and safety. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112480015A details a novel one-pot Pd-catalyzed method for synthesizing 2-trifluoromethyl quinazolinones using nitro compounds, offering significant cost and efficiency advantages.
Patent CN102603624A reveals a scalable Pd-catalyzed route for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN112250614B details a metal-free, one-pot synthesis of 3-spiro-tricyclic indolones using NBS, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN108033866B details a green Ru-catalyzed cyclization for naphthalene derivatives, offering cost reduction in optoelectronic material manufacturing and high-purity pharmaceutical intermediates.
Patent CN113354573A reveals a scalable route for alpha,alpha-terpyridine. Eliminate palladium residues and achieve 99.4% purity for optical and pharma applications.
Patent CN112939780A details a Rh-catalyzed C-H activation route for indanone derivatives, offering high yields and functional group tolerance for reliable pharmaceutical intermediate supply.
Novel Pd-catalyzed carbonylation route for quinolinone derivatives offering high yields and simplified purification for pharmaceutical intermediates.
Patent CN113735777B reveals a metal-free route for cyclic thiourea compounds. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical intermediates.
Patent CN111606808A reveals a mild Suzuki coupling method for Fluxapyroxad intermediates, offering high purity and scalable production capabilities.
Patent CN112778352B details a novel Pd-catalyzed ortho-C-H silylation method. This route offers high atom economy and streamlined supply chains for pharmaceutical intermediates.
Novel metal-free synthesis method for high-purity azaspiro intermediates offering cost reduction and supply chain reliability for pharmaceutical manufacturing processes
Novel patent CN111978194A details a safe carbonylation method using benzyl formate. Offers cost-effective routes for high-purity pharmaceutical intermediates with simplified supply chains.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles disclosed in CN110467579B. Cost-effective, scalable route for API intermediates without heavy metals.
Novel FeX3 catalyzed method for pyrroles replaces noble metals. High purity, green chemistry, and cost-effective solutions for API manufacturing.
Novel mild method for alpha-aryl nitriles using aryl sulfoxides and tin reagents. High yield, scalable process for reliable pharmaceutical intermediate supply chain.
Patent CN118515639A reveals efficient Pd-catalyzed route. Offers significant cost reduction and supply reliability for high purity pharma intermediates manufacturing.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles. Offers cost-effective, scalable routes for API intermediates without heavy metals.
Novel room-temperature synthesis of trifluoromethyl 1,2,4-triazines via sulfur ylide cycloaddition. Offers cost reduction in API manufacturing and scalable production.